OBJECTIVE	We hypothesised that melatonin may represent a safe somniferous drug for cardiac patients , and assessed the effects of administering 5 mg of melatonin daily before bedtime for 30 days in patients with coronary artery disease ( CAD ) regarding changes in the nocturnal breathing pattern .\